HUTCHMED Correlations
H7T2 Stock | EUR 2.76 0.06 2.22% |
The current 90-days correlation between HUTCHMED LS 1 and Eagle Materials is 0.09 (i.e., Significant diversification). The correlation of HUTCHMED is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
HUTCHMED Correlation With Market
Significant diversification
The correlation between HUTCHMED LS 1 and DJI is 0.07 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED LS 1 and DJI in the same portfolio, assuming nothing else is changed.
HUTCHMED |
The ability to find closely correlated positions to HUTCHMED could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HUTCHMED when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HUTCHMED - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HUTCHMED LS 1 to buy it.
Moving together with HUTCHMED Stock
Moving against HUTCHMED Stock
0.72 | BFP | BBVA Banco Frances | PairCorr |
0.68 | TM2 | Sydbank AS | PairCorr |
0.57 | 92I | ROMERIKE SPAREBANK | PairCorr |
0.5 | 5F3 | JINS HOLDINGS INC | PairCorr |
0.7 | PTX | Palantir Technologies | PairCorr |
0.65 | 2WY | Wyndham Hotels Resorts | PairCorr |
0.61 | UFH | US FOODS HOLDING | PairCorr |
0.61 | D4G | Datametrex AI Limited | PairCorr |
0.6 | QAN | Qantas Airways | PairCorr |
0.54 | C6TB | CHINA BANK ADR20 | PairCorr |
0.49 | NT4 | Northern Trust | PairCorr |
0.49 | AF4 | HANOVER INSURANCE | PairCorr |
0.47 | 4GE | Grupo Mxico SAB | PairCorr |
0.47 | PNP | PNC Financial | PairCorr |
0.41 | WX1 | Acadia Realty Trust | PairCorr |
0.39 | D2V | PARKEN Sport Enterta | PairCorr |
0.36 | FFH | Fifth Third Bancorp | PairCorr |
0.32 | AQHE | Event Hospitality | PairCorr |
0.7 | 2T9A | TRAINLINE PLC LS | PairCorr |
0.69 | VAI | Vail Resorts | PairCorr |
0.62 | PPB | Flutter Entertainment PLC | PairCorr |
0.61 | APC | Apple Inc | PairCorr |
Related Correlations Analysis
0.56 | 0.98 | 0.59 | 0.61 | 0.34 | -0.03 | E5M | ||
0.56 | 0.57 | 0.84 | 0.85 | 0.83 | -0.45 | GTR | ||
0.98 | 0.57 | 0.63 | 0.64 | 0.34 | -0.04 | E5M | ||
0.59 | 0.84 | 0.63 | 1.0 | 0.68 | -0.62 | VMC | ||
0.61 | 0.85 | 0.64 | 1.0 | 0.69 | -0.62 | VMC | ||
0.34 | 0.83 | 0.34 | 0.68 | 0.69 | -0.5 | 3GX | ||
-0.03 | -0.45 | -0.04 | -0.62 | -0.62 | -0.5 | AP2 | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between HUTCHMED Stock performing well and HUTCHMED Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze HUTCHMED's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
E5M | 1.42 | (0.11) | 0.00 | (0.12) | 0.00 | 3.52 | 10.37 | |||
GTR | 2.14 | 0.24 | 0.08 | 2.39 | 2.46 | 6.12 | 19.95 | |||
E5M | 1.27 | (0.10) | 0.00 | (0.15) | 0.00 | 2.31 | 13.71 | |||
VMC | 1.18 | 0.21 | 0.12 | 0.73 | 1.04 | 2.31 | 13.38 | |||
VMC | 1.11 | 0.20 | 0.12 | 1.75 | 1.00 | 1.75 | 12.91 | |||
3GX | 2.14 | 0.15 | 0.05 | (1.59) | 2.11 | 6.11 | 11.50 | |||
AP2 | 1.75 | (0.13) | 0.00 | (0.36) | 0.00 | 3.83 | 16.86 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in HUTCHMED without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
All Next | Launch Module |
HUTCHMED Corporate Management
Elected by the shareholders, the HUTCHMED's board of directors comprises two types of representatives: HUTCHMED inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HUTCHMED. The board's role is to monitor HUTCHMED's management team and ensure that shareholders' interests are well served. HUTCHMED's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HUTCHMED's outside directors are responsible for providing unbiased perspectives on the board's policies.
Edith Shih | Company Secretary, Non-Executive Director | Profile | |
May Wang | Senior Vice President - business development & strategic alliances | Profile | |
Mark Lee | Senior Vice President - Corporate Finance & Development | Profile | |
Karen Ferrante | Independent Non-Executive Director | Profile | |
Weiguo Su | Chief Scientific Officer, Executive Director | Profile |